Aspergillus fumigatus is the most common and life-threatening aerial fungal pathogen, especially among immunocompromised hosts. Understanding the pathobiology of this pathogen requires investigations both to characterise the immunosuppressive status of the phagocytic cells that usually kill the fungus in the immunocompetent host, and to identify fungal virulence factors that either promote the resistance of conidia to innate immunity or stimulate mycelial growth in the lung parenchyma. Recent findings are presented in this review and show how little we know of the interactions between host and pathogen. Now the genome of A. fumigatus has been sequenced, transcriptome/ proteome-based studies should disclose the multiple facets of A. fumigatus pathogenicity. 
at that time aspergillosis was generally considered a disease of pigeon breeders. Until the 1980s, aspergillosis was considered to be a rare disease, occuring among people with previously formed lung infection cavities caused by diseases such as tuberculosis. The exotic status of A. fumigatus has, however, changed in recent years owing to the increase in the number of immuno-suppressed patients and the degree of severity of immuno-suppressive therapies. A. fumigatus is now the most prevalent airborne fungal pathogen, and causes severe and usually fatal invasive infections in immuno-compromised hosts in developed countries (Denning, 1998 , Latgé, 1999 (Table 1) .
after inhalation has not been quantified. The role of the epithelium in the establishment of IA has not been carefully analysed yet, although several observations suggest that the epithelium could serve as a focus of infection: (1) epithelial cells can engulf conidia which subsequently remain alive intracellularly (Paris et al., 1997; Wasylnka & Moore, 2002) ; (2) the lung epithelium is damaged following immunosuppressive therapies (irradiation and drugs) and graft rejection (Cordonnier et al., 1996) facilitating the binding of conidia to altered or activated epithelial cells ; and (3) corticosteroids, a risk factor for IA, reduce the release or efficacy of antimicrobial peptides and proteins constitutively synthesized at epithelial surfaces (Travis et al., 1999) .
Alveola
Conidia that have not been trapped intracellularly at the epithelial level end up in the alveola where they encounter the main lung phagocytic cell, the alveolar macrophage (AM). Conidial engulfment is very quick (1-2h) and not affected by the immune status of the host. Killing of conidia, mainly due to reactive oxygen intermediates (ROIs), starts 6-8 hours after phagocytosis. The killing rate is surprisingly slow with only a 10% or less reduction in conidia after 6 hours of phagocytosis. These data correlate well with the slow elimination rate of conidia seen in the lungs of mice More recently, another poltical and environmental issue has arisen concerning A. fumigatus. In its natural habitat, this species is found in high concentrations in compost. Surrounding compost plants, conidial concentrations higher than 10 6 conidia/m 3 are often encountered, with similar conidial concentrations often found in material arriving at the composting plant and in the resulting commercial product (Beffa et al., 1998 ; Millner et al., 1977) . This may represent a biological hazard for the general population, as A. fumigatus is known to produce polypeptide allergens responsible for asthma and rhinitis, mycotoxins and ß1,3 glucans that are known modulators of the immune system (Heederik et al., 2000; Fisher et al., 2000; Rylander, 1999 , Sigsgeard et al., 2000 . The allergy risk for the normal population has not been carefully evaluated, especially as symptoms of non-fungal allergy may be exacerbated following exposure to A. fumigatus. In the absence of a serious evaluation of the allergic and infectious risks, A. fumigatus may represent a biological 'excuse' to prevent the establishment of a composting plant in a selected site.
Apart from this environmental issue, the major problem caused by A. fumigatus remains invasive aspergillosis (IA). In spite of a dramatic increase in incidence, the pathobiology of A. fumigatus remains poorly understood.
Establishment of the disease
Investigations aiming to discover the initial sites of A. fumigatus infection, an essential event in the understanding of IA, have been limited. Fig 2 shows that two putative pulmonary sites of infection can be suspected: the epithelium and the alveola.
Lung epithelium
The majority of conidia of A. fumigatus, like most aerolized particles, are excluded from the lung through the ciliary action of the mucous epithelium, although the proportion of conidia not excluded mechanically following a respiratory challenge (2-3 days depending on the initial inoculum load) (Levitz et al., 1986; Philippe et al, 2003) . Immunosuppression by corticoids is associated with a reduction in ROI production that is correlated with the intramacrophagic germination seen in these patients.
Polymorphonuclear neutrophils (PMN) are recruited to the lung following extracellular fungal germination. They represent the third line of defence against A. fumigatus, explaining why neutropenia (a reduction in neutrophil numbers, particularly common as a result of chemotherapy) favours IA. Contact between neutrophils and hyphae triggers the secretion of reactive oxygen intermediates and enzymatic granule components. In contrast to the killing of conidia by macrophages, hyphal damage by PMN is rapid. As for AM, corticosteroids are also associated with a failure of the PMN phagocytic response in controlling A. fumigatus (Diamond & Clark, 1982 ; Levitz & Farrell, 1990 ; Rex et al., 1990) .
As mentioned earlier, identification of the sites of infection and putative latency of this fungus in the lung compartment in the IC patient would markedly help our understanding of the pathobiology of the infection and could lead to efficient prophylactic interventions that have not been applicable to date for IA.
Analysis of fungal aggressiveness
Invasive aspergillosis results from the growth in the lung of a branched, septate vegetative mycelium that will invade the lung tissues. Virulence of A. fumigatus could then be due to fungal molecules that either promote mycelial growth specifically into the lung parenchyma or are responsible for a higher resistance of A. fumigatus to the debilitated antifungal mechanisms of the immunocompromised human host. These molecules should be absent from other thermophyllic airborne pathogens, a control always forgotten in the analysis of A. fumigatus virulence!
Tools and strategies to analyse fungal virulence
To date, the study of A. fumigatus virulence is based on the analysis of mutants constructed by gene disruption, and the detection of attenuated virulence of the mutant through an animal screen (Latgé, 2001) . Two strategies have been used to investigate A. fumigatus virulence using mutants. In the first approach, putative virulence factors are selected in advance. This selection is based on the biochemical function of the protein, which should putatively help the invading mycelium to grow in vivo. The main drawback of this approach is that identification of the function of the protein is based on a fungus grown in vitro. The second approach has been the construction of libraries of mutants by random insertional mutagenesis. Early studies used the integration of a selection marker such as hygromycin (Brown et al, 2000) but the integration of a transposon is now most commonly used (Firon, 2002) .
Animal models play a central role in the identification of a virulence factor. Although mice are the most commonly used test animals, there is no consensus about the best experimental model to use. Even though immunosuppressive treatments substantially increase the susceptibility of animals to infection, and intranasal inoculation mimics the natural route of infection and seems to be a more appropriate route than intravenous injection, an animal model has not yet been developed that effectively mimics chronic infection caused by the inhalation of a low number of conidia (Latgé, 1999) . In the usual approach to the study of virulence, strains of A. fumigatus are inoculated into separate groups of animals and death is monitored over time. This method is only appropriate to identify mutant strains characterized by high differences in virulence. Models involving mixtures of strains are more useful in quantifying slight variations in strain aggressiveness not detected when isolates are inoculated individually (Sarfati et al., 2002) .
Putative virulence factors of A. fumigatus
No true virulence factors have been identified to date in A. fumigatus. In particular, the catalase, proteases and toxin secreted by this fungus do not play a role in the pathogenesis of A. fumigatus in experimentally-induced infections. Genes identified to date as playing a role in disease development are shown in Table 2 . PABA or PyrG auxotrophs are not able to germinate in the lung because the chemicals correcting auxotrophy are absent from the lung (Brown et al., 2000 ; d'Enfert et al., 1996) . Strains with reduced growth rate, such as those obtained by disruption of the cell wall chitin synthase (Aufauvre- Brown et al., 1996) or glucanosyltransferase (Mouyna et al., submitted), are less pathogenic than wild type parental strains. The importance of growth rate over the total growth can be emphasized in revisiting a double protease mutant that we constructed a few years ago (Jaton-Ogay et al., 1994) . When these mutants were plated on an agar medium with or without 1% BSA, the growth rate of the mutant and wild type was not modified, whereas the total mycelial dry weight was reduced by the double mutation (Fig 3) . No difference in mortality was seen between the mutant and parental strain, confirming that the growth rate is a key factor for growth in vivo.
Fig 3 Growth and infectivity of a double alkaline serine protease/metalloprotease mutant (alp mep) and its parental strain (WT).
A: note that in a medium supplemented with bovine serum albumin (BSA), total mycelial growth is higher in the wild type strain. B: hyphal extension is identical in mutant and parental strains in agar media with or without BSA (dotted line indicates colony diameter). C: note no difference of virulence is seen in a mixed model of infection between wt and alp mep strains.
The role of nutrient availability can also be correlated with low infectivity, for example in the case of the areA mutant, a global nitrogen regulatory gene in Aspergillus (Hensel et al., 1998) .
Attenuated virulence has also been associated with the disruption of genes involved in the resistance of the fungus to the phagocytic immune response (Tsai et al, 1999; Jahn et al, 2000) . Mutants with white conidia resulting from the inactivation of the ALB1 gene, a polyketide synthase essential for the synthesis of dihydroxynaphtalene melanin in A. fumigatus, were more efficiently damaged by phagocytes than the wildtype. The melanin layer of the conidial cell wall efficiently scavenges reactive oxygen species and plays a major role in protection against the phagocytic reactions. The value of this observation can be questioned as it is extremely rare to isolate strains from the environment with white conidia. In addition, using an intravenous murine infection model, the virulence of white conidia was reduced by approximately 20-50% of that observed with wild-type, but non-pigmented conidia were still able to induce IA when inoculated intranasally into steroid-treated mice (Sarfati et al., 2002) .
This observation led us to question whether all environmental strains of A. fumigatus have the same virulence potential and whether epidemiological studies could bring new insights into strain pathogenicity. No difference in growth was observed for hundreds of airborne strains analysed in our laboratory (unpublished observations). Strain variability was scrutinized more deeply using DNA fingerprinting methods such as Southern blot patterns of restricted DNA probed with retrotransposon-like elements such as Afut1 and Afut2, or microsatellite length polymorphisms (Bart Delabesse et al. 2001) . A survey of hundreds of isolates showed that as many as 85% of the environmental isolates investigated displayed unique genotypes, and that these strains were detected only once within a two year-period from the same environment (Chazalet et al. 1998) . No particular strains were indeed isolated repeatedly from the same specific hospital. Patients suffering from IA or from aspergilloma are however usually infected by one or two strains only (Fig 4) . In addition, when bronchial colonization occurs in the absence of invasive aspergillosis, e.g. in patients with cystic fibrosis, data gathered to date indicate that patients colonized by A. fumigatus usually harbour several strains that were found recurrently per patient (Neuvéglise et al., 1997) .
The presence of one or two strains per patient with invasive and/or disseminated infections, despite the presence of thousands of genotypes from the environment potentially inhaled by the patient, could have two explanations (Fig 4) . Firstly, infection is random and the strains that predominate are the first to grow at a time when the patient is the most susceptible. Secondly, clinical isolates are more virulent than environmental isolates. Typing of environmental and patients' isolates did not show any clustering among clinical and environmental strains suggesting that every environmental strain should be considered a potential pathogen for any appropriate host at risk of infection. If every isolate of A. fumigatus is potentially pathogenic, then detection of one/two genotypes per patient would more likely reflect competition among isolates for infection or colonization at one point in time, rather than the existence of isolates with different levels of virulence. Indeed, IA can be easily induced in animal models with any strain isolated from the environment or from a different host. However, recent data, using intravenous or intranasal assays with a mixture of different strains as an inoculum, have suggested that strains selected randomly from a laboratory collection have different pathogenicities since poorly infective strains could not be recovered (Sarfati et al. 2002) . These preliminary data were unexpected and suggest that there are differences in virulence between environmental isolates. Such studies should be pursued with a higher number of strains, especially since two studies using other murine models of invasive aspergillosis have suggested clinical isolates to be more virulent than environmental isolates (Mondon et al., 1995; Aufauvre-Brown et al., 1998) .
Conclusion
Single gene disruption studies have not been able to identify a true virulence factor for A. fumigatus, viz., a gene or a protein essential for growth in vivo whose deletion does not affect mycelial growth in vitro. It is then tempting to speculate that the virulence of A. fumigatus is directly correlated with its specific biological characteristics, namely the small size of conidia allowing their dispersal throughout the entire respiratory tract, rapid mycelial growth at temperatures around 37°C, and absence of specific nutritional requirements. However, the fact that A. fumigatus is responsible for in excess of 90% of human pulmonary mycosis would suggest that this fungal species displays some molecular features that favour its development in human tissues. Earlier studies have suggested that virulence of A. fumigatus may be polygenic; further analysis of A. fumigatus virulence would require the identification of global regulators or multiple genes expressed concomittantly in the same metabolic pathway. To date, the most efficient way to reach this objective is a comparative transcriptome and/or proteome analysis of the fungus grown in vitro and in vivo. Such an approach is now feasible since the sequence of the entire genome of A. fumigatus, although not annotated yet, is available at http://www.tigr.org/tdb/e2k1/afu1.
One of the key events in the establishment of aspergillosis is the resistance of A. fumigatus to phagocytosis and its slow killing in vivo. Moreover, even though alveolar macrophages and neutrophils have been shown repeatedly to play an essential role in the killing of A. fumigatus conidia and germ tubes respectively in the immuno-competent host, the molecular mechanisms debilitated by the immunotherapies remain to be elucidated. Similarly, studies of cross-talk between T cells and phagocytes remain limited to an analysis of Th1/Th2 cytokine patterns in murine aspergillosis without considering human IA infections. These are key research areas to develop if one wants to improve protective immunity against this fungal infection.
